Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy.
Viganó
A
A
Saresella
M
M
Rusconi
S
S
Ferrante
P
P
Clerici
M
M
D036541:ADP-ribosyl Cyclase; D051997:ADP-ribosyl Cyclase 1; D015703:Antigens, CD / Q000032:analysis*; D000943:Antigens, Differentiation / Q000032:analysis*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002648:Child; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage*; D019259:Lamivudine / Q000008:administration & dosage*; D008562:Membrane Glycoproteins; D009244:NAD+ Nucleosidase / Q000032:analysis*; D018119:Stavudine / Q000008:administration & dosage*; D014766:Viremia / Q000821:virology*
D015703:Antigens, CD; D000943:Antigens, Differentiation; D008562:Membrane Glycoproteins; D019259:Lamivudine; D019469:Indinavir; D018119:Stavudine; D036541:ADP-ribosyl Cyclase; C498154:CD38 protein, human; D009244:NAD+ Nucleosidase; D051997:ADP-ribosyl Cyclase 1